Načítá se...
Timing of GLP-1 Receptor Agonist Initiation for Treatment of Type 2 Diabetes in the UK
INTRODUCTION: Patients with type 2 diabetes mellitus (T2DM) who fail to meet glycaemic control are at increased risk of diabetes complications. For patients who cannot maintain glycaemic control with oral medication, one recommended option is to add an injectable glucagon-like peptide-1 receptor ago...
Uloženo v:
| Vydáno v: | Drugs R D |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer International Publishing
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6544605/ https://ncbi.nlm.nih.gov/pubmed/31115873 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-019-0273-0 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|